Prostate MRI: Who, when, and how? Report from a UK consensus meeting - Abstract

The current pathway for men suspected of having prostate cancer [transrectal biopsy, followed in some cases by magnetic resonance imaging (MRI) for staging] results in over-diagnosis of insignificant tumours, and systematically misses disease in the anterior prostate.

Multiparametric MRI has the potential to change this pathway, and if performed before biopsy, might enable the exclusion of significant disease in some men without biopsy, targeted biopsy in others, and improvements in the performance of active surveillance. For the potential benefits to be realized, the setting of standards is vital. This article summarizes the outcome of a meeting of UK radiologists, at which a consensus was achieved on (1) the indications for MRI, (2) the conduct of the scan, (3) a method and template for reporting, and (4) minimum standards for radiologists.

Written by:
Kirkham AP, Haslam P, Keanie JY, McCafferty I, Padhani AR, Punwani S, Richenberg J, Rottenberg G, Sohaib A, Thompson P, Turnbull LW, Kurban L, Sahdev A, Clements R, Carey BM, Allen C.   Are you the author?
Department of Imaging, University College Hospital, London, UK.

Reference: Clin Radiol. 2013 Jul 1. pii: S0009-9260(13)00184-0.
doi: 10.1016/j.crad.2013.03.030


PubMed Abstract
PMID: 23827086

UroToday.com Prostate Cancer Section

 

 

email news signup